Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tango Therapeutics (TNGX) Return on Assets: 2021-2025

Historic Return on Assets for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to -0.45%.

  • Tango Therapeutics' Return on Assets fell 11.00% to -0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.45%, marking a year-over-year decrease of 11.00%. This contributed to the annual value of -0.36% for FY2024, which is 12.00% down from last year.
  • Per Tango Therapeutics' latest filing, its Return on Assets stood at -0.45% for Q3 2025, which was up 21.07% from -0.57% recorded in Q2 2025.
  • Tango Therapeutics' 5-year Return on Assets high stood at -0.10% for Q3 2021, and its period low was -0.57% during Q2 2025.
  • Its 3-year average for Return on Assets is -0.34%, with a median of -0.30% in 2024.
  • Its Return on Assets has fluctuated over the past 5 years, first increased by 6bps in 2022, then dropped by 27bps in 2025.
  • Tango Therapeutics' Return on Assets (Quarterly) stood at -0.11% in 2021, then dropped by 13bps to -0.24% in 2022, then remained steady at -0.24% in 2023, then declined by 14bps to -0.39% in 2024, then declined by 11bps to -0.45% in 2025.
  • Its Return on Assets stands at -0.45% for Q3 2025, versus -0.57% for Q2 2025 and -0.45% for Q1 2025.